Why Organon (OGN) is Poised to Beat Earnings Estimates Again

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Organon (OGN) . This company, which is in the Zacks Medical Services industry, shows potential for another earnings beat.When looking at the last two reports, this pharmaceutical company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 9.63%, on average, in the last two quarter ...